DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nucleoside analogue
Nucleoside analogue
Design and Evaluation of 5•²-O-Dicarboxylic And
Recent Advances in Antiviral Therapy J Clin Pathol: First Published As 10.1136/Jcp.52.2.89 on 1 February 1999
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescent Living With
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patien
Rational Design and Synthesis of New Nucleoside Analogues Bearing a Cyclohexane Core
1. Global HIV Infection Drug Market Overview 1.1 Global HIV Incidence Scenario 1.2 Market Overview: Global & Regional 1.3 Clinical Pipeline Overview
Review Nucleoside Analogue-Sparing Strategy for the Treatment of Chronic HIV Infection: Potential Interest and Clinical Experience Véronique Joly* and Patrick Yeni
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018
Hydroxyurea with Ddi Or Ddi/D4t: a Novel Approach to HIV Therapy
Antiviral Research and Development Against Dengue Virus
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
LAMIVUDINE and ZIDOVUDINE Tablets Safely and Effectively
Mitochondria Are Sensors for HIV Drugs
Drug Discovery of Nucleos(T)Ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80Th Birthday
Lactic Acidemia in Infection with Human Immunodeficiency Virus
Delstrigo (Doravirine/Lamivudine/Tenofovir
VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-Of-Concept Study for Antiviral-Hyperactivation Limiting Therapeutics
Top View
Case Report Lamivudine Therapy for a Hepatitis B Surface Antigen
The Evolution of Antiviral Nucleoside Analogues a Review for Chemists
Perspectives for Antivirals to Limit SARS-Cov-2 Infection (COVID-19)
Treatment of HIV Infection with Didanosine and Foscarnet
V Nucleoside/Nucleotide RT Inhibitor (NRTI) Resistance
Effects of Switching to Protease Inhibitor Monotherapy on Nucleoside Analogue-Related Adverse Events
Antiviral Treatment for Chronic Hepatitis B Virus Infection – Immune Modulation Or Viral Suppression?
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2019
Nucleoside Analogue Reverse Transcriptase Inhibitor Options: A
Safety of HIV/Hepc Protease Inhibitors
Prescribing Information for These Drugs
Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Truvada, MINN-Emtricitabine/Tenofovir
Surveillance of Sexually Transmitted Infections in Primary Care
Lipid Derivatives of Antiviral Nucleosides, Liposomal Incorporation and Method of Use
The Anti–Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus
Protease Inhibitors: a New Weapon and a New Strategy Against HIV
New Nucleoside Analogs for the Treatment of Chronic Hepatitis B